Shigekazu Nagata
Osaka University
439 Papers
8.3K Citations
Shigekazu Nagata is an academic researcher from Osaka University. The author has contributed to research in topics: Apoptosis & Fas ligand. The author has an hindex of 124, co-authored 428 publications. Previous affiliations of Shigekazu Nagata include Nara Institute of Science and Technology & University of Tokyo.
Chat about Author
Papers
Transcriptional Control of Inflammatory
Jordan S. Pober,William C. Sessa,Stephen T. Smale,Gioacchino Natoli,Surya Pandey,Taro Kawai,Shizuo Akira,Kohki Kawane,Kou Motani,Shigekazu Nagata +9 more
- 01 Jan 2014
TL;DR: This collection focuses on Innate Immunity and Inflammation Lipid Mediators in the Resolution of Inflammational, and examines their role in immunity, immunity and disease.
11
Three individual regulatory elements of the promoter positively activate the transcription of the murine gene encoding granulocyte colony-stimulating factor
TL;DR: At least three regulatory elements GPE1, GPE2 and GPE3 (G-CSF promoter elements) controlling the gene encoding granulocyte colony-stimulating factor are indispensable for the constitutive expression of the G- CSF gene in human CHU-2 cells and for its lipopolysaccharide(LPS)-inducible expression in macrophages.
11
Interferon-induced TRAIL-independent cell death in DNase II-/- embryos.
TL;DR: It is shown that TRAIL is dispensable for inducing the apoptosis of erythroid cells in DNase II−/− embryos, and therefore, that there is a TRAIL‐independent mechanism for the IFN‐induced apoptosis.
9
Patent
Fas LIGAND, PART THEREOF, AND DNA CODING FOR THE SAME
Shigekazu Nagata,Takashi Suda,Tomohiro Takahashi,Norio Nakamura +3 more
- 10 Nov 1994
TL;DR: A Fas ligand useful in the medicinal field and a part thereof, a novel DNA coding for the same; an antibody; a recombinant DNA molecule containing the above DNA; a transformant; a method of purifying the novel protein; a process for producing the novel proteins; a novel protein antibody; an oligonucleotide complementary to a Fas l ligand gene; and a method for screening a substance associated with the fas ligand as discussed by the authors.
9
The Use of Site-Directed Mutagenesis in Reversed Genetics
Charles Weissmann,Shigekazu Nagata,Tadatsugu Taniguchi,Hans Weber,François Meyer +4 more
- 01 Jan 1979
TL;DR: The application of reversed genetics to phage Qβ and the extension of site-directed mutagenesis to cloned eukaryotic DNA are described.
8